Recommendations for testing and evaluation of drugs as to carcinogenicity
Schramm, T.; Schwabe, K.; Gibel, W.
Archiv für Geschwulstforschung 37(1): 53-65
1971
ISSN/ISBN: 0003-911X PMID: 4102700 Document Number: 37800
Document emailed within 1 workday
Related Documents
Collins, T.M.; Zimmerman, D.R. 1992: Programs for monitoring inappropriate prescribing of controlled drugs: evaluation and recommendations American Journal of Hospital Pharmacy 49(7): 1765-17681992: Complementary testing criteria for veterinary drugs applied in animals for choice meat production. Recommendations by the Drug Advisory Commission of the Royal Dutch Society for Veterinary Medicine Tijdschrift Voor Diergeneeskunde 117(13): 393-399
Feron, V.J.; Griesemer, R.A.; Nesnow, S.; Anders, F.; Bannasch, P.; Becker, R.; Becking, G.; Cabral, J.R.; Della Porta, G.; Henschler, D. 1986: Testing of complex chemical mixtures (for carcinogenicity) Iarc Scientific Publications 1986(83): 483-494
Steinhoff, D. 1981: Possible methods of carcinogenicity testing for substances used at the place of work Cancer Detection and Prevention 4(1-4): 41-46
Venkataramaiah, T.; Gajanana, A. 1987: Evaluation of Plasmodium falciparum-microsomal in vitro system for testing pro-drugs Indian Journal of Medical Research 86: 579-581
Preussmann, R.; Habs, M.; Pool, B.L. 1979: Carcinogenicity and mutagenicity testing of three isomeric N-nitroso-N-methylaminopyridines in rats Journal of the National Cancer Institute 62(1): 153-156
1997: Medical recommendations and references about hypolipidemic drugs. ANDEM (National Agency for the Development of Medical Evaluation Journal des Maladies Vasculaires 22(4): 249-264
Berger, M.R. 1986: Carcinogenicity of alkylating cytostatic drugs in animals Iarc Scientific Publications 78: 161-176
Schmähl, D. 1986: Carcinogenicity of anticancer drugs and especially alkylating agents Iarc Scientific Publications 78: 29-35
Weisburger, E.K.; Russfield, A.B.; Homburger, F.; Weisburger, J.H.; Boger, E.; Van Dongen, C.G.; Chu, K.C. 1978: Testing of twenty-one environmental aromatic amines or derivatives for long-term toxicity or carcinogenicity Journal of Environmental Pathology and Toxicology 2(2): 325-356
Yamamoto, S.; Hayashi, Y.; Mitsumori, K.; Nomura, T. 1997: Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene Laboratory Animal Science 47(2): 121-126
Radman, M.; Kinsella, A.R. 1980: Chromosomal events in carcinogenic initiation and promotion: implications for carcinogenicity testing and cancer prevention strategies Iarc Scientific Publications 1980(27): 75-90
Bend, J.R.; Foureman, G.L.; Ben-Zvi, Z.; Albro, P.W. 1984: Heterogeneity of hepatic aryl hydrocarbon hydroxylase activity in feral winter flounder: relevance to carcinogenicity testing National Cancer Institute Monograph 65: 359-370
Ti, L.; Hayashi, K.; Kaplan, K.; Suwannawong, P.; Fu, E.; Wood, E.; Kerr, T. 2012: HIV testing and willingness to get HIV testing at a peer-run drop-in centre for people who inject drugs in Bangkok, Thailand Bmc Public Health 12: 189
2003: Recommendations for clinical practice. Review of diagnosis and treatment of migraine in the adult and child October 2002. Professional recommendations and references: economic evaluation service Revue Neurologique (Paris) 159(6-7 Part 2): S5-15
2003: Recommendations for clinical practice. Review of diagnosis and treatment of migraine in the adult and child October 2002. Professional recommendations and references: economic evaluation service Revue Neurologique (Paris) 159(6-7 Part 2): S5-15
Bartlett, J.G. 1988: Testing for HIV infection: recommendations for surgeons Bulletin of the American College of Surgeons 73(3): 4-10
Hamilton, T.E.; Grover, S. 1980: Pulmonary function testing: regulations and recommendations Occupational Health and Safety 49(7): 25-29; 50
Magdorf, K. 1996: Recommendations for tuberculin testing in childhood for Germany Pneumologie 50(7): 474-475
Feely, M.A.; Collins, C.Scott.; Daniels, P.R.; Kebede, E.B.; Jatoi, A.; Mauck, K.F. 2013: Preoperative testing before noncardiac surgery: guidelines and recommendations American Family Physician 87(6): 414-418